The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review.

Lucy S Witt Jessica R Howard-AndersonJesse T JacobLindsey B Gottlieb

Published in: JAC-antimicrobial resistance (2022)

Coronavirus disease 2019 (COVID-19) changed healthcare across the world. With this change came an increase in healthcare-associated infections (HAIs) and a concerning concurrent proliferation of MDR organisms (MDROs). In this narrative review, we describe the impact of COVID-19 on HAIs and MDROs, describe potential causes of these changes, and discuss future directions to combat the observed rise in rates of HAIs and MDRO infections.

Keyphrases

coronavirus disease
healthcare
multidrug resistant
gram negative
sars cov
respiratory syndrome coronavirus
drug resistant
acinetobacter baumannii
signaling pathway
squamous cell carcinoma
klebsiella pneumoniae
cystic fibrosis
pseudomonas aeruginosa
risk assessment
escherichia coli
human health
rectal cancer